Findings show KIFC1 links poor prognosis and immune response in clear cell renal cell carcinoma, suggesting its potential as a therapeutic target.
KIFC1 serves as a multifunctional molecule linking epithelial-mesenchymal transition, immune modulation, and treatment resistance. It may be a promising prognostic biomarker and therapeutic target in ccRCC, warranting further functional and clinical investigation.
No takes yet. Share an insight, caveat, or question.
Nakano et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: